Navigation Links
Combination Products Executive Forum to be Hosted by CHI's Pharmaceutical Strategy Series

Business Executives, Pricing Analysts, and IP Professionals Meet on Expanding their Combination Products Research and Partnerships on June 1-2, 2009 in Cambridge, MA.

Needham, MA (PRWEB) February 13, 2009 -- The Pharmaceutical Strategy Series, a division of Cambridge Healthtech Institute, recently posted details for its next executive forum - Combination Products: Improving Product Life Cycles, Extending Lines, and Creating Novel Therapeutics to be held on June 1-2, 2009 at the Royal Sonesta Hotel in Cambridge, MA. This executive forum will focus on the practical interplay between combination product research, development challenges, and commercial and partnering strategies, as well as the implications for successful market realization.

Session Topics include:

  • Creative Product Development, Portfolio Management, and Line Extension Strategies using Combination Products
  • Regulatory Implications - Anticipating Regulatory Hurdles and New Developments
  • The Market Advantage of Combination Products - Analysis and Strategies for Positioning
  • Commercial Strategies for Success - Market Acceptance and Reimbursement
  • Development Challenges of Combination Products

According to Micah Lieberman, Executive Director of the Pharmaceutical Strategy Series, "We are delighted to have organized this executive forum for the pharmaceutical, biologics and medical devices industries to help companies leverage new business opportunities and intellectual property for their existing (and future) products. Pharmaceutical Strategy Series' executive forums have become known as networking platforms that bring together senior-level executives, analysts, and industry experts. I am also pleased to announce the support of Epstein Becker & Green, P.C. as our sponsor," states Lieberman.

Bradley Merrill Thompson, General Counsel to the Combination Products Coalition and Shareholder at Epstein Becker & Green, P.C. commented: "We look forward to present our perspective on overcoming the regulatory hurdles with combination products. To be compliant and competitive in the marketplace, combination product companies must stay current with regulatory developments and initiatives impacting the combination product industry. Delegates attending this conference will be better positioned to ensure the success of their company's combination products," says Thompson.

Prior to the start of this executive forum will be a pre-conference workshop: Economic Value-Based Product Design for Combination Drugs.

For full details and to register for the conference and/or pre-conference workshop, visit

To receive a press pass, email Tracey Fielding at

About Cambridge Healthtech Institute
Founded in 1992, Cambridge Healthtech Institute ( is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI's portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech's Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

About The Pharmaceutical Strategy Series
A division of Cambridge Healthtech Institute, the Pharmaceutical Strategy Series ( produces executive-level conferences that bring together R&D leaders and corporate executives to assess business opportunities, enhance corporate value, and forecast the economic and regulatory landscape within the rapidly changing pharmaceutical & biotechnology industries. PSS conferences are uniquely designed to maximize peer-to-peer networking and idea sharing.

James Prudhomme
Cambridge Healthtech Institute
(781) 972-5400

# # #

Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy
2. Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer
3. If Herceptin is Approved in Combination With Other Emerging Therapies it Will be in a Position to Retain Patient Share From Tykerb/Tyverb for the Treatment of HER2-Positive Breast Cancer
4. Drug combinations key in treating neurodegenerative diseases
5. InterMune Reports Results from Triple Combination Study of ITMN-191
6. Scientists call up stem cell troops to repair the body using new drug combinations
7. Identifies Toxic Combination
8. Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne
9. Drug Combinations Putting Seniors at Risk
10. Holiday Treats and Decorations Can Be a Deadly Combination for Pets
11. QLT announces interim results of radical study evaluating Visudyne combination therapy
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... It’s inevitable that everyone ... member, close friend, or animal pass away, death lives among us. It is your ... Coming from a family of 11 children, author T Sky understands that she may ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... announce the speakers for “Value-Based Payer-Provider Partnerships: Three Case Studies,” an upcoming ... value-based care arrangements: Essentia Health and UCare, MissionPoint Health Partners, and Intel ...
(Date:11/30/2015)... IL (PRWEB) , ... November 30, 2015 , ... The ... an emerging pharmaceutical company. Because it is so important to this key industry segment, ... Factors in your IND Filing” on December 4th at 11am EST. , Federal law ...
(Date:11/30/2015)... ... November 30, 2015 , ... Insightra Medical, Inc. ... Surgical Mesh technology for soft tissue repair in the US via Insightra’s national ... resorbable surgical mesh intended to support and reinforce soft tissue for 6-9 months ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... & Laser Center is one of a select few plastic surgeons in the ... non-surgical fat removal. , SculpSure™ is the world’s first heat-induced laser treatment for ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... -- Booth #4303 – The Imaging Components business of Varian ... array of products in a new booth (#4303) at the ... America in Chicago this ... components "At the Heart of Imaging." Products will include a ... Claymount brand, and computer-aided diagnostic software from MeVis as well ...
(Date:11/30/2015)... -- Hanger, Inc. (NYSE: HGR ) (the "Company") today ... its previously announced consent solicitation (as amended and restated, ... amount 7⅛% Senior Notes due 2018 (the "Notes") to ... pursuant to the Consent Solicitation, (ii) the proposed increased ... date of the Consent Solicitation.    ...
(Date:11/30/2015)... , Nov. 30, 2015   VolitionRx Limited (NYSE ... diagnostic tests for a broad range of cancer types and ... LD Micro Conference, which will be held December 1 - 3 ... from VolitionRx will be David Kratochvil , Chief Financial ... of Investor Relations. ® blood-based tests for ...
Breaking Medicine Technology: